Join us at AAPS 2021 PharmSci 360 from Oct. 17-20, 2021, in Philadelphia, PA.
Learn more about Element’s pharmaceutical testing services, including our microbiology and analytical chemistry testing options. Visit us in Booth #114 or request a meeting below to learn more about how Element's extractables and leachables, raw materials and microbiology testing services can help keep your project on track.
About the event
PharmSci 360 offers more than 100 sessions featuring content and discussions on current industry trends and concerns. The sessions are split among six topic tracks:
- Discovery and Basic Research
- Preclinical Development
- Bioanalytics
- Clinical Pharmacology
- Manufacturing and Analytical Characterization
- Formulation and Delivery
Connect with industry experts to share ideas and learn about new innovations, trends, regulations and more.
Book a meeting
Schedule a meeting with one of our experts to learn more about how we can help you to develop better products, save time and money, and minimize potential risk to your business.
Nearly 190 Years of Making Certain
More from Element
On-demand Webinar: E&L Considerations for Customized Syringe Delivery
Dr. James Scull, Scientific Director for Element Life Sciences, discusses a case study that explores the E&L consideration of custom drug delivery systems in order to meet regulatory requirements.
Watch Now
Pharmaceutical Raw Material and Finished Product Testing
Our raw material and finished product testing bring peace of mind to manufacturers of drug products ensuring the safety, purity, and quality of both starting materials and manufactured products.
read more
Sterility and Rapid Sterility
Ensuring product sterility is critical to patient health and safety, so a fast turnaround time is essential to delivering critical medicines to the patients who depend on them. Element offers USP <71> Sterility testing and rapid sterility testing options.
Read More
White Paper: Mycoplasma Safety Testing in Pharmaceutical Products
Contaminated cell cultures and products have the potential to cause serious illness in humans. Download our white paper at the link below for an overview of mycoplasma testing and considerations to address when executing these studies.
Download